Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Acrivon Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   8-K8-KS-1/A
Revenues   [+]23.913.71.9
            Revenue growth  74.6%621.2% 
Cost of goods sold  32.716.23.2
Gross profit  -8.7-2.5-1.3
            Gross margin  -36.4%-18.0%-66.6%
Selling, general and administrative   [+]8.72.51.3
Other operating expenses  15.211.30.6
EBITDA   [+]  -3.2
            EBITDA margin  -136.4%-118.0%-165.9%
Depreciation and amortization    0.0
EBIT   [+]-32.7-16.2-3.2
            EBIT margin  -136.4%-118.0%-166.6%
Other income (expense), net  1.5-0.13.2
Pre-tax income  -31.2-16.20.0
Income taxes  0.00.00.0
            Tax rate  0.0%0.0% 
Net income  -31.2-16.20.0
            Net margin  -130.1%-118.4%0.0%
   
Basic EPS   [+]($7.56)($9.32)$0.00
Diluted EPS   [+]($7.56)($9.32)$0.00
   
Shares outstanding (basic)   [+]4.11.71,432.5
Shares outstanding (diluted)   [+]4.11.71,432.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy